Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Clin |
RCV003231157 | SCV003930280 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2023-05-20 | reviewed by expert panel | curation | The ClinGen RYR1-MHS variant curation expert panel is focused on assessing variants in RYR1 for pathogenicity as related to malignant hyperthermia susceptibility (MHS) inherited in an autosomal dominant pattern. Variants in RYR1 can also cause other myopathies inherited in an autosomal dominant pattern or in an autosomal recessive pattern. Some of these disorders may predispose individuals to malignant hyperthermia. RYR1 variants may also contribute to a malignant hyperthermia reaction in combination with other genetic and non-genetic factors and the clinician needs to consider such factors in making management decisions. This sequence variant predicts a substitution of Arginine with Glycine at codon 2508 of the RYR1 protein, p.(Arg2508Gly). This variant was not present in a large population database (gnomAD) at the time this variant was interpreted. This variant has been reported in individuals with a personal or family history of an MH episode or central core disease but without sufficient information to consider the reports for informing PS4 in relation to MHS inherited in an autosomal dominant pattern (PMID:16621918, PMID:16732084, PMID:19346234). Functional studies in HEK293 cells show an increased sensitivity to RYR1 agonists, PS3_Moderate, (PMID:26381711). This variant does not reside in a hotspot for pathogenic variants that contribute to MHS. Another variant that has been assessed as likely pathogenic occurs at this codon, p.(Arg2508His), PM5_Supporting (PMID:30236257). A REVEL score of 0.844 supports neither a pathogenic nor a benign status for this variant. This variant has been classified as a Variant of Unknown Significance. Criteria implemented: PS3_Moderate, PM5_Supporting. |
| Prevention |
RCV000119717 | SCV000852779 | uncertain significance | not provided | 2020-05-04 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV000119717 | SCV002512916 | pathogenic | not provided | 2022-04-19 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect on calcium homeostasis (Vukcevic et al., 2010; Miyoshi et al., 2015); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19346234, 20142353, 16732084, 25989378, 30499100, 32381029, 31301762, 16917943, 26381711, 16621918) |
| Leiden Muscular Dystrophy |
RCV000119717 | SCV000154624 | not provided | not provided | no assertion provided | not provided |